Want to join the conversation?
$NTAP 1Q16 Q&A: Kurtz from Sterne Agee asked about expectation for product GM. Nick explained product GM for 1Q16 vs. 1Q15 was pretty significant decline in GM percentage. Over the course of the year in terms of Product GM, we're going to expect that FX certainly paid in the back half of the year. So we will be back to typical.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?